| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.ULTRASMEDBIO.2016.05.005 |
| P698 | PubMed publication ID | 27302657 |
| P50 | author | Judith C Sluimer | Q40504181 |
| Klazina Kooiman | Q51226622 | ||
| Katja Steiger | Q52699946 | ||
| Mat J A P Daemen | Q73172570 | ||
| A. F. W. van der Steen | Q102210076 | ||
| P2093 | author name string | Nico de Jong | |
| Ben J Janssen | |||
| Johan G Bosch | |||
| Andrew Needles | |||
| Verya Daeichin | |||
| Ilya Skachkov | |||
| Thomas L Theelen | |||
| P2860 | cites work | Regulation of macrophage foam cell formation by alphaVbeta3 integrin: potential role in human atherosclerosis | Q24297558 |
| Molecular Imaging of Platelet-Endothelial Interactions and Endothelial von Willebrand Factor in Early and Mid-Stage Atherosclerosis | Q27339951 | ||
| Macrophage activation in atherosclerosis: pathogenesis and pharmacology of plaque rupture | Q28212820 | ||
| Integrins: a family of cell surface receptors | Q28288125 | ||
| Requirement of vascular integrin alpha v beta 3 for angiogenesis | Q29619681 | ||
| Ultrasound assessment of inflammation and renal tissue injury with microbubbles targeted to P-selectin | Q30308172 | ||
| Noninvasive assessment of angiogenesis by ultrasound and microbubbles targeted to alpha(v)-integrins | Q30310466 | ||
| Imaging tumor angiogenesis with contrast ultrasound and microbubbles targeted to alpha(v)beta3. | Q30310994 | ||
| Ischemic memory imaging in nonhuman primates with echocardiographic molecular imaging of selectin expression | Q30407883 | ||
| A comparative evaluation of ultrasound molecular imaging, perfusion imaging, and volume measurements in evaluating response to therapy in patient-derived xenografts | Q30412053 | ||
| Ultrasound molecular imaging of tumor angiogenesis with an integrin targeted microbubble contrast agent. | Q30432690 | ||
| Microbubbles in medical imaging: current applications and future directions | Q30433669 | ||
| Microbubble contrast agents: targeted ultrasound imaging and ultrasound-assisted drug-delivery applications | Q30439569 | ||
| Noninvasive ultrasound molecular imaging of the effect of statins on endothelial inflammatory phenotype in early atherosclerosis | Q30455730 | ||
| Ultrasonic imaging of endothelial CD81 expression using CD81-targeted contrast agents in in vitro and in vivo studies | Q30455981 | ||
| Molecular imaging of inflammation and intraplaque vasa vasorum: a step forward to identification of vulnerable plaques? | Q30479243 | ||
| Vasa vasorum and atherosclerosis - Quid novi? | Q30483491 | ||
| Targeted imaging using ultrasound | Q30734358 | ||
| Plaque-associated vasa vasorum in aged apolipoprotein E-deficient mice exhibit proatherogenic functional features in vivo | Q34513266 | ||
| Neovascularization in human atherosclerosis | Q34523545 | ||
| Tumor angiogenic marker expression levels during tumor growth: longitudinal assessment with molecularly targeted microbubbles and US imaging | Q34591102 | ||
| From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II. | Q35558849 | ||
| Endovascular therapies for noncoronary atherosclerosis in the elderly: aortoiliac and femorotibial lesions | Q36193245 | ||
| Alphavbeta3-integrin imaging: a new approach to characterise angiogenesis? | Q36514879 | ||
| Molecular imaging of inflammation and platelet adhesion in advanced atherosclerosis effects of antioxidant therapy with NADPH oxidase inhibition. | Q36617730 | ||
| Molecular imaging with targeted contrast ultrasound | Q36714700 | ||
| Inhibition of extracellular signal-regulated kinase signaling to prevent cardiomyopathy caused by mutation in the gene encoding A-type lamins. | Q37089986 | ||
| Analysis of in situ and ex vivo vascular endothelial growth factor receptor expression during experimental aortic aneurysm progression. | Q37364420 | ||
| Molecular imaging reveals rapid reduction of endothelial activation in early atherosclerosis with apocynin independent of antioxidative properties | Q37466636 | ||
| Ultrasound molecular imaging of atherosclerosis | Q37506868 | ||
| Intraplaque haemorrhages as the trigger of plaque vulnerability | Q37852494 | ||
| Targeted ultrasound contrast agents for ultrasound molecular imaging and therapy | Q38364441 | ||
| Molecular Acoustic Angiography: A New Technique for High-resolution Superharmonic Ultrasound Molecular Imaging | Q38810997 | ||
| Quantification of bound microbubbles in ultrasound molecular imaging. | Q38864916 | ||
| Composition of carotid atherosclerotic plaque is associated with cardiovascular outcome: a prognostic study | Q39881547 | ||
| Ultrasound contrast agents as markers of vascularity and microcirculation | Q39951639 | ||
| Molecular profiling of angiogenesis with targeted ultrasound imaging: early assessment of antiangiogenic therapy effects | Q40024036 | ||
| Hypothesis: vasa vasorum and neovascularization of human coronary arteries. A possible role in the pathophysiology of atherosclerosis | Q41543829 | ||
| Therapeutic Use of Avidin Is Not Hampered by Antiavidin Antibodies in Humans | Q42477444 | ||
| Evaluation of alphavbeta3 integrin-targeted positron emission tomography tracer 18F-galacto-RGD for imaging of vascular inflammation in atherosclerotic mice | Q43266220 | ||
| Molecular imaging of angiogenesis in early-stage atherosclerosis with alpha(v)beta3-integrin-targeted nanoparticles | Q44616397 | ||
| Nonlinear Contrast Imaging with an Array-Based Micro-Ultrasound System | Q44660017 | ||
| Imaging of angiogenesis using Cadence contrast pulse sequencing and targeted contrast agents | Q44927479 | ||
| Atherosclerotic plaque disruption induced by stress and lipopolysaccharide in apolipoprotein E knockout mice | Q46087953 | ||
| Hypoxia, hypoxia-inducible transcription factor, and macrophages in human atherosclerotic plaques are correlated with intraplaque angiogenesis | Q46678597 | ||
| Molecular targeting of lymph nodes with L-selectin ligand-specific US contrast agent: a feasibility study in mice and dogs | Q47672457 | ||
| Intravascular ultrasound molecular imaging of atheroma components in vivo | Q47972229 | ||
| Histological assessment of 526 symptomatic carotid plaques in relation to the nature and timing of ischemic symptoms: the Oxford plaque study | Q48559037 | ||
| Subharmonic, non-linear fundamental and ultraharmonic imaging of microbubble contrast at high frequencies | Q50048391 | ||
| Molecular imaging of human thrombus with novel abciximab immunobubbles and ultrasound. | Q51040468 | ||
| Far-wall pseudoenhancement during contrast-enhanced ultrasound of the carotid arteries: clinical description and in vitro reproduction. | Q53174707 | ||
| Plaque Neovascularization Is Increased in Ruptured Atherosclerotic Lesions of Human Aorta | Q56986958 | ||
| α v β 3 Integrin Expression in Normal and Atherosclerotic Artery | Q71807379 | ||
| A novel site-targeted ultrasonic contrast agent with broad biomedical application | Q71958393 | ||
| In vivo targeting of acoustically reflective liposomes for intravascular and transvascular ultrasonic enhancement | Q74611644 | ||
| Ultrasound molecular imaging contrast agent binding to both E- and P-selectin in different species | Q84590342 | ||
| Vasa vasorum and plaque neovascularization on contrast-enhanced carotid ultrasound imaging correlates with cardiovascular disease and past cardiovascular events | Q84895072 | ||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | endothelium | Q111140 |
| microbubble | Q6839290 | ||
| P1104 | number of pages | 11 | |
| P304 | page(s) | 2283-2293 | |
| P577 | publication date | 2016-06-11 | |
| P1433 | published in | Ultrasound in Medicine and Biology | Q2260380 |
| P1476 | title | Quantification of Endothelial αvβ3 Expression with High-Frequency Ultrasound and Targeted Microbubbles: In Vitro and In Vivo Studies | |
| P478 | volume | 42 |
| Q93017847 | Applications of Ultrasound to Stimulate Therapeutic Revascularization |
| Q51031499 | Microbubble Enzyme-Linked Immunosorbent Assay for the Detection of Targeted Microbubbles in in Vitro Static Binding Assays. |
| Q90346534 | Microbubble Formulations: Synthesis, Stability, Modeling and Biomedical Applications |
| Q53132563 | Sentinel Lymph Node Characterization with a Dual-Targeted Molecular Ultrasound Contrast Agent. |
| Q51744923 | Simplified Preparation of αvβ3 Integrin-Targeted Microbubbles Based on a Clinically Available Ultrasound Contrast Agent: Validation in a Tumor-Bearing Mouse Model. |
| Q38604554 | Ultrasound and magnetic resonance molecular imaging of atherosclerotic neovasculature with perfluorocarbon magnetic nanocapsules targeted against vascular endothelial growth factor receptor 2 in rats |
Search more.